NASDAQ:BDMD Baird Medical Investment (BDMD) Stock Price, News & Analysis $0.83 -0.01 (-0.82%) As of 12:52 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsNews and TrendsOwnershipSEC Filings About Baird Medical Investment Stock (NASDAQ:BDMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BDMD alerts:Sign Up Key Stats Today's Range$0.79▼$0.9250-Day Range$0.84▼$1.2252-Week Range$0.74▼$3.70Volume88,777 shsAverage Volume790,295 shsMarket Capitalization$35.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Baird Medical Investment Holdings Limited (NASDAQ: BDMD) is a medical device company focused on minimally invasive tumor-treatment technologies. Through its operating subsidiaries, the company develops, manufactures and sells microwave ablation systems and related medical consumables used in image-guided procedures. Its product portfolio is primarily designed for the treatment of thyroid nodules and other solid tumors, including applications involving the liver, lung and breast. Microwave ablation uses heat generated by electromagnetic energy to destroy targeted tissue and is typically performed with ultrasound or other imaging guidance. Baird Medical was established in China and serves healthcare providers in the Chinese market, with products used by hospitals and medical institutions. The company has also indicated an interest in expanding its international presence. Publicly available information about its current leadership and operations outside China is limited.AI Generated. May Contain Errors. Read More Baird Medical Investment Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks21st Percentile Overall ScoreBDMD MarketRank™: Baird Medical Investment scored higher than 21% of companies evaluated by MarketBeat, and ranked 808th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingBaird Medical Investment has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageBaird Medical Investment has only been the subject of 1 research reports in the past 90 days.Read more about Baird Medical Investment's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth75.00% Earnings GrowthEarnings for Baird Medical Investment are expected to grow by 75.00% in the coming year, from $0.08 to $0.14 per share. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.39% of the float of Baird Medical Investment has been sold short.Short Interest Ratio / Days to CoverBaird Medical Investment has a short interest ratio ("days to cover") of 0.97, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baird Medical Investment has recently increased by 42.31%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBaird Medical Investment does not currently pay a dividend.Dividend GrowthBaird Medical Investment does not have a long track record of dividend growth. News and Social Media1.7 / 5News Sentiment-0.33 News SentimentBaird Medical Investment has a news sentiment score of -0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Baird Medical Investment this week, compared to 2 articles on an average week.Search Interest1 people have searched for BDMD on MarketBeat in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Baird Medical Investment insiders have not sold or bought any company stock.Percentage Held by Insiders78.90% of the stock of Baird Medical Investment is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions19.78% of the stock of Baird Medical Investment is held by institutions.Read more about Baird Medical Investment's insider trading history. Receive BDMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baird Medical Investment and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BDMD Stock News HeadlinesFY2026 Earnings Estimate for BDMD Issued By Zacks ResearchSeptember 18, 2026 | americanbankingnews.comBaird Medical to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 15, 2026 | globenewswire.comA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Across the country, protests, lawsuits, and moratoria are targeting AI infrastructure projects. Whitney Tilson, former hedge fund manager and editor of Stansberry's Investment Advisory, says November 4 could bring this conflict to a head, with major implications for investors' portfolios.September 22 at 1:00 AM | Stansberry Research (Ad)Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation TechnologySeptember 14, 2026 | globenewswire.comBaird Medical Investment (NASDAQ:BDMD) Trading 1.9% Higher - Time to Buy?September 12, 2026 | americanbankingnews.comBDMD: Baird Medical reports strong revenue growth for the 6-month period ending 6/30/26September 10, 2026 | msn.comBaird Medical Swings To H1 Profit As Revenue Rises 24.6%September 3, 2026 | rttnews.comBaird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026September 3, 2026 | globenewswire.comSee More Headlines BDMD Stock Analysis - Frequently Asked Questions How have BDMD shares performed this year? Baird Medical Investment's stock was trading at $1.36 at the start of the year. Since then, BDMD stock has decreased by 38.1% and is now trading at $0.8420. Who are Baird Medical Investment's major shareholders? Top institutional investors of Baird Medical Investment include Citadel Advisors LLC (0.13%). How do I buy shares of Baird Medical Investment? Shares of BDMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Baird Medical Investment own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baird Medical Investment investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), Baidu (BIDU). Company Calendar Today9/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1d) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 BDMD's financial health is in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:BDMD Previous SymbolNASDAQ:BDMD CIK1982444 WebN/A Phone86 159 1316 5120FaxN/AEmployees146Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$22.54 million Price / Sales1.56 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares42,210,000Free Float8,906,000Market Cap$35.20 million OptionableN/A Beta-1.15 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:BDMD) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredChina's dominance in rare earth processing sparks new defense rulesOn January 1, 2027, new Pentagon rules tighten sourcing restrictions on critical minerals tied to foreign adve...The Tomorrow Investor | SponsoredArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Acro...Stansberry Research | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baird Medical Investment Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Baird Medical Investment With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
